Skip Navigation
Wilmer Eye Institute
Print This Page
Share this page: More

Retinopathy of Prematurity

Retinopathy of Prematurity (ROP) is an eye condition that affects premature infants (infants weighing less than 1250 grams or those born before 31 weeks gestation). ROP is a common cause of childhood vision loss and can have significant visual consequences including blindness. Not all premature infants develop ROP and not all infants with ROP have lasting visual consequences or require treatment.

In more severe cases, infants may require extensive treatment including laser and cryotherapy. These treatments decrease the oxygen demand in the retina in an attempt to save the vision. Vision loss from ROP is variable and patients may experience central or peripheral vision loss. In addition, ROP can lead to retinal detachments requiring more invasive surgery with more significant effects on the vision.

Vision rehabilitation for patients with ROP is specific to the type of vision loss and the age at presentation to the Vision Rehabilitation Service. Early on, we often assist with making recommendations for the Individualized Education Plan (IEP) while the patient is in school. Determining the visual potential is an important part of the rehabilitative process and it helps to make informed decisions on the best learning style.

After completion of school, we can offer assistance with vocational and independent living goals. Patients with ROP may have central visual impairment and thus would require magnification. Many patients with ROP have significant peripheral visual impairment and require mobility aids such as a white cane and we will often refer for orientation and mobility training. In more significant cases of visual impairment, patients with ROP may require Braille instruction or sensory substitution such as text to speech conversion and auditory input for extended reading even if some vision is preserved. The vision rehabilitative management of ROP is very specific to the individual patient’s type of vision loss and the specific goals.

Dr. Pradeep Ramulu and Colleagues Study Relationship Between Vision Loss and Work Status - 7/18/2014

Wilmer Resident Receives Lindstrom Research Grant - 7/11/2014

Four Wilmer Researchers Receive BrightFocus Foundation Awards - 7/10/2014

Dr. Michael Repka Part of Team Researching Telemedicine and ROP - 6/27/2014

Dr. M. Valeria Canto-Soler and Colleagues Featured on WBAL-TV - 6/24/2014

Dr. M. Valeria Canto-Soler and Colleagues Use Human Stem Cells to Create Light-Sensitive Retina in a Dish - 6/10/2014

Wilmer's Division of Ocular Immunology Announces "Living With Uveitis" Support Group - 6/10/2014

Dr. Neil Bressler to Speak on Diabetic Retinopathy at National Eye Health Summit and Webcast - 6/10/2014

Dr. Donald Zack Receives a Research to Prevent Blindness Nelson Trust Award for Retinitis Pigmentosa - 6/9/2014

Dr. Michael Boland Leads Study on Effectiveness of Automated Telecommunication-Based Reminders on Adherence to Glaucoma Medication Dosing - 6/4/2014

Dr. Christina Prescott Discusses Summer Eye Protection on Fox 45 News - 6/1/2014

Dr. Jonathan Song Discusses Treatment Options for Pediatric Cataracts - 5/23/2014

Johns Hopkins' Jordan Green Discusses His Work at Wilmer's Translational Tissue Engineering Center - 5/21/2014

Longtime Wilmer Employee Lillie Alston Honored by Hopkins - 5/19/2014

Dr. Richard Semba: Diets Rich in Antioxidant Resveratrol Fail to Reduce Deaths, Heart Disease or Cancer - 5/12/2014

Dr. Neil Miller Explains Eye Twitching in The Wall Street Journal - 5/12/2014

Dr. Hendrik Scholl Receives ARVO Award - 5/7/2014


Traveling for care?

blue suitcase

Whether crossing the country or the globe, we make it easy to access world-class care at Johns Hopkins.

U.S. 1-410-464-6713 (toll free)
International +1-410-614-6424



© The Johns Hopkins University, The Johns Hopkins Hospital, and Johns Hopkins Health System. All rights reserved.

Privacy Policy and Disclaimer